对12例肝癌采用经肝动脉灌注化疗栓塞治疗，观察临床疗效。
Methods 12 patients with liver cancer used TACE then observed clinical efficacy.
目的：探讨以奥沙利铂为主的肝动脉灌注化疗对结直肠癌多发肝转移患者的治疗效果。
AIM: To evaluate the efficacy of hepatic arterial infusion chemotherapy (HAIC) based on oxaliplatin for treatment of the patients with multiple liver metastases from colorectal cancer.
目的研究经肝动脉灌注热化疗药治疗肝癌的有效性及安全性。
Objective To investigate the effectiveness and safety of transhepatic arterial infusion of warm chemotherapeutic agents in treating hepatic cancer.
目的经肝动脉介入性灌注与热灌注化疗治疗中晚期肝癌，观察对比病灶大小、生存期。
Objective To observe and compare the volumes and survival periods of tumors in the patients with advanced liver cancer after treatments of transhepatic arterial infusion and heat infusion.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
结论经肝动脉超选择性灌注32 P玻璃微球内照射化疗栓塞治疗肝癌是一种安全有效的方法。
Conclusions Super selective intra-arterial radioembolization with 32 P-glass microspheres is an effective and safe method in treatment of liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
目的评价联合应用肝动脉栓塞灌注化疗和部分性脾栓塞治疗肝癌患者脾功能亢进的临床价值。
Objective To study the clinical effect and method of the partial splenic embolization (PSE) in the treatment of hypersplenism.
目的评价联合应用肝动脉栓塞灌注化疗和部分性脾栓塞治疗肝癌患者脾功能亢进的临床价值。
Objective To study the clinical effect and method of the partial splenic embolization (PSE) in the treatment of hypersplenism.
应用推荐